Onco-Innovations Limited (NEO:ONCO)
0.4000
0.00 (0.00%)
Sep 28, 2026, 4:00 PM EST
Onco-Innovations Revenue
Onco-Innovations had revenue of 90.88K CAD in the twelve months ending July 31, 2026, up 7.18% year-over-year. In the fiscal year ending April 30, 2026, Onco-Innovations had annual revenue of 110.38K with 69.06% growth.
Revenue (ttm)
90.88K
Revenue Growth
+7.18%
P/S Ratio
304.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 110.38K | 45.09K | 69.06% |
| Apr 30, 2025 | 65.29K | - | - |
| Apr 30, 2024 | - | - | - |
| Apr 30, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Onco-Innovations News
- 6 days ago - Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform - Accesswire
- 6 days ago - Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform - Accesswire
- 12 days ago - Onco-Innovations Announces Closing of Shares for Debt Settlement - TheNewswire
- 19 days ago - IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Islam Mohamed, Chief Medical Officer of Onco-Innovations Ltd. - GlobeNewsWire
- 19 days ago - Onco-Innovations Provides Interim Report on Microsome Studies Across Three Species - TheNewswire
- 20 days ago - Onco-Innovations Announces Shares for Debt Settlement - TheNewswire
- 5 weeks ago - Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program - Accesswire
- 6 weeks ago - Onco-Innovations Advances ONC010 Polymer Development with Identification of Non-Tin Catalyst and Provides Integrated Update - TheNewswire